Beginning September 28th, all patients tested for covid-19 by Fulgent Genetics, Temple City, Calif, will also receive results for influenzas A and B. “With flu season fast approaching, we believe it will be critical to differentiate between influenza and SARS-CoV-2, and that this combination of virus testing will become the standard of care during the remainder of the pandemic,” says Brandon Perthuis, chief commercial officer of Fulgent Genetics. “Adding Influenza A and B testing to our covid-19 testing solution further solidifies Fulgent Genetics as the go-to laboratory for testing during this pandemic, as it has become increasing clear that RT-PCR is the gold standard for covid-19 testing.” The addition of influenza A and B testing will apply to all Fulgent covid-19 tests and platforms including drive-through testing, enterprise testing for back-to-work and back-to-school, facility-based testing, as well as its FDA-authorized Picture at-home test. For more information, visit Fulgent Genetics.
September 18, 2020
July 1, 2020